Trials / Conditions / Urethra Cancer
Urethra Cancer
5 registered clinical trials studyying Urethra Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer NCT02300610 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Completed | A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function NCT02665039 | Dr Anders Ullén | Phase 2 |
| Completed | Phase I Study With Sorafenib in Addition to Vinflunine in Metastatic Transitional Cell Carcinoma of the Urothe NCT01844947 | Dr Anders Ullén | Phase 1 |
| Completed | A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial C NCT01326871 | Altor BioScience | Phase 1 / Phase 2 |
| Completed | A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer NCT00661609 | AstraZeneca | Phase 2 |